Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-6-27
|
pubmed:abstractText |
Four clones of pancreatic secretory trypsin inhibitor (PSTI)-overexpressing cells (TF-PANC clones 1, 6, 8, and 36) were established to evaluate the physiological function of PSTI secreted by cancer cells, by means of introducing a PSTI-expression vector (pRSV-PSTI) into the human pancreatic adenocarcinoma cell line (PANC-1). No obvious changes were observed in the histological features of these transplanted tumors in nude mice, in the growth of TF-PANC and PANC-1, or that of 3T3 fibroblasts when cocultured with them. Addition of recombinant human PSTI to the cultured media resulted in no increase in proliferation of fibroblasts (3T3 and WI-38) or of four pancreatic cancer cell lines (PANC-1, CAPAN-I, MIAPaCa-2, and Hs766T). These results suggest that the estimation of tumor-bearing PSTI as a paracrine or autocrine growth factor in recent studies should be given careful consideration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0169-4197
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-73
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8195643-3T3 Cells,
pubmed-meshheading:8195643-Adenocarcinoma,
pubmed-meshheading:8195643-Animals,
pubmed-meshheading:8195643-Growth Substances,
pubmed-meshheading:8195643-Humans,
pubmed-meshheading:8195643-Mice,
pubmed-meshheading:8195643-Mice, Inbred BALB C,
pubmed-meshheading:8195643-Mice, Nude,
pubmed-meshheading:8195643-Neoplasm Transplantation,
pubmed-meshheading:8195643-Pancreatic Neoplasms,
pubmed-meshheading:8195643-Recombinant Proteins,
pubmed-meshheading:8195643-Trypsin Inhibitor, Kazal Pancreatic,
pubmed-meshheading:8195643-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.
|
pubmed:affiliation |
Department of Surgery II, Osaka University Medical School, Japan.
|
pubmed:publicationType |
Journal Article
|